Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2981278 in Psoriasis Plaque Test
NCT02548052Phase 1Completed
- Sponsor
- GSK
- Start
- Oct 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GSK2981278 in plaque psoriasis, sponsored by GSK. Primary endpoints: Number of subjects with adverse events, Change from baseline in clinical laboratory parameters at Day 19 and 5 more. Started Oct 2015; status: completed.
02
Drugs
GSK2981278
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02548052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02548052.